- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01324674
Relationship Between Treatment With Bach´s Flower Remedy and Spiritual Well-Being of People With Common Mental Disorder
January 16, 2012 updated by: Ana Paula Corrêa Castello Branco Nappi Arruda, UPECLIN HC FM Botucatu Unesp
The Common Mental Disorders (CMD) refer to health states involving non-psychotic psychiatric symptoms.
Part of this broad diagnostic category, symptoms such as difficulty concentrating, forgetfulness, insomnia, fatigue, irritability, feelings of worthlessness, somatic complaints, etc.
The CMD has a big social impact, and its prevalence in the general population is 25% and graduate students in health care reaches 40%.
The Bach´s Flower Remedies are considered a complementary therapy approved and recommended by World Health Organization and by the Brazilian Ministry of Health and in his theory it has great spiritual nature.
In addition, international scientific research have suggested that the strengthening of spiritual well-being can help significantly and positively promoting mental health.
This project aims to assess the relationship between treatment with Bach´s Flower Remedies and Spiritual well-being of people with Common Mental Disorders in undergraduate health students of a university located in São José dos Campos, state of São Paulo, Brazil.
This research presents a quantitative and qualitative methodology, experimental clinical trial, triple blind.
The treatment will take place with two groups of forty people, the group of treatment and the placebo´s.
The trial will happen in six sessions at intervals of 30 days, totaling eight months of treatment.
Statistical analysis will be used chi-square or Fisher exact test to study the association between the scale of spiritual well-being and the use of Bach Flowers for each time point (3 times).
To compare the evolution of the results (scales) during the study will set a model for ordinal data with repeated measurements over time.
For these statistical tests is assumed a significance level of 5% (p < 0.005).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
70
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
São Paulo
-
São José dos Campos, São Paulo, Brazil, 12244000
- University of Vale do Paraiba
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- People over 18 years old
- People who have read and agreed to participate by signing an informed consent
- People who obtain scores equal to or above 8 for women and equal to or above 6 for men in SRQ - 20
- People who does not ingest medication
- People who does not use any type of complementary therapy and integrative such as Herbal Medicine, Aromatherapy, Homeopathy, Flower Essences, Reiki, acupuncture, etc.
Exclusion Criteria:
- Not meet the assumptions of the inclusion criteria
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Placebo group
Is the group of subjects that will take placebo
|
The subjects will have a solution non-drug type, 4 drops 4 times per day, for approximately 8 months
Other Names:
|
Experimental: experimental group
Is the group of subjects that will take Bach´s Flower remedies
|
The subjects will have 4 drops 4 times per day, for approximately 8 months.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Self-Reporting Questionnaire (SRQ-20)
Time Frame: (8 months) In 3 times: the first one in the first visit, the second one in the third visit and the last one in the sixth visit.
|
The Self-Reporting Questionnaire was developed by Harding et al. (1980), from four other instruments used for screening for possible mental disorders.
The development of this instrument was coordinated by World Health Organization (WHO) and aimed to reach a possible instrument to identify cases in primary care services and community, especially in developing countries with lack of services and professionals.
The intention of the WHO was to identify cases from the instrument and to encourage planners to provide services and mental health care to the needy population (WHO, 1994).
|
(8 months) In 3 times: the first one in the first visit, the second one in the third visit and the last one in the sixth visit.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Spiritual Index of Well-Being Scale (SIWBS)
Time Frame: (8 months) 3 times after the intervention: the first one in the first visit, the second one in the third visit and the last one in the sixth visit
|
This instrument, translated and validated into Portuguese from the Index of Spiritual Well-Being Scale (SIWBS) is a research tool that aims to assess the influence of spiritual values in the spiritual welfare of individuals.
|
(8 months) 3 times after the intervention: the first one in the first visit, the second one in the third visit and the last one in the sixth visit
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Ivan A Guerrini, PhD, Medical School of São Paulo State University (UNESP)
- Study Chair: Ruth Turrini, PhD, Nursing School of University of São Paulo - (EEUSP)
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2011
Primary Completion (Actual)
December 1, 2011
Study Completion (Actual)
December 1, 2011
Study Registration Dates
First Submitted
February 21, 2011
First Submitted That Met QC Criteria
March 28, 2011
First Posted (Estimate)
March 29, 2011
Study Record Updates
Last Update Posted (Estimate)
January 18, 2012
Last Update Submitted That Met QC Criteria
January 16, 2012
Last Verified
March 1, 2011
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- upeclin/HC/FMB-Unesp-50
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mental Disorders
-
Kansas State UniversityAugusta University; Dartmouth College; University of CincinnatiEnrolling by invitationMental Disorders, Severe | Mental Illness PersistentUnited States
-
VA Boston Healthcare SystemUS Department of Veterans AffairsCompletedMental Health DisordersUnited States
-
Virginia Commonwealth UniversityCompletedMental Health DisordersUnited States
-
Johns Hopkins UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMental Health DisordersCongo
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompletedMental Health DisordersNorway
-
York UniversityCanadian Institutes of Health Research (CIHR); North York General HospitalCompletedMental Health DisordersCanada
-
University of ManchesterEuropean Research CouncilRecruitingMental Disorders, SevereUnited Kingdom
-
Fundació Institut de Recerca de l'Hospital de la...Active, not recruitingMental Disorders, SevereSpain
-
University of North Carolina, Chapel HillU.S. Department of JusticeCompletedMental Disorders, SevereUnited States
-
Liga Romana pentru Sanatate MintalaPsychiatric Hospital for Chronic Patients Siret, Suceava, RomaniaUnknown
Clinical Trials on Placebo group
-
Pusan National University Yangsan HospitalCompletedDyspepsiaKorea, Republic of
-
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...Active, not recruiting
-
University of Sao Paulo General HospitalCompletedSpinal Cord InjuriesBrazil
-
University of PernambucoUnknown
-
Karaman Training and Research HospitalRecruiting
-
Universidad Europea de MadridMinisterio de Economía y Competitividad, SpainCompleted
-
Universidad San SebastiánUnknownCervical Pain | Musculoskeletal ManipulationsChile
-
Pusan National University Yangsan HospitalCompletedSubjective Memory ImpairmentKorea, Republic of
-
RWTH Aachen UniversityTerminatedStroke | Upper Limb ParesisGermany
-
Université de SherbrookeAlzheimer's Association; Nestle Health ScienceRecruiting